![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
Reset all filters
01 1Methylphenidate ER
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2016 Revenue in Millions : 104
2015 Revenue in Millions : 137
Growth (%) : -24
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2017 Revenue in Millions : 72
2016 Revenue in Millions : 126
Growth (%) : -43
LOOKING FOR A SUPPLIER?